You can&#x27;t correct for inadequate sample sizes with statistics and still expect a clinically relevant result (the confidence interval would be too large). The issue isn&#x27;t contamination in small samples, it&#x27;s that the biomarkers they need to measure may not be accurately measurable at such small volumes - in particular with the value ranges required for the test.<p>It may just be that their &quot;nanotainer&quot; tests may only be viable for boolean tests like their herpes test (herpes DNA present - yes &#x2F; no).